Decline in Rejection in the First Year After
International Progress In Heart Transplantation and The “Vienna Factor” Mandeep R. Mehra, MD President, International Society For Heart and Lung Transplantation.
Are we ready to implant LVAD’s in the less sick? Ileana L. Piña, MD, MPH Professor of Medicine and Epi/Pop Health Albert Einstein College of Medicine Associate.
Antibody-Mediated Rejection: Prevention, Pathophysiology,Treatment, Brenda Muth, RN, MS, ACNP Transplant Nephrology and Desensitization.
Donor Utilization: Making Use of a Precious Resource in Cardiac Transplant Jason W. Smith, MD Assistant Professor of Surgery The University of Washington.
1 ADVANCED HEART FAILURE RECOGNIZING OPTIONS John M. Herre, MD, FACC, FACP Director, Advanced Heart Failure Program Sentara Helathcare Professor of Medicine.
Presentations: Quantifying the impact of adverse events on HRQOL early after implant Patient selection and estimation of prognosis using health status.
International Progress In Heart Transplantation and The “Vienna Factor”
Humoral Rejection in Allografts And Gene Expression Anatasia Gangadin Dr. Mario C Deng Columbia University College of Physicians and Surgeons.
Dr. Holger Buchholz Clinical Assistant Professor Division of Cardiac Surgery Director Pediatric Artificial Heart Program University of Alberta, Stollery.
ISHLT – 2013 Call for Abstracts / Preliminary Program
ADVANCED HEART FAILURE RECOGNIZING OPTIONS
